
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 23, 2020, titled "Sun Pharma Announces the Launch of ILUMYA�� (tildrakizumab) for Treatment of Plaque Psoriasis in Japan".
Filed with NSE ·

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 23, 2020, titled "Sun Pharma Announces the Launch of ILUMYA�� (tildrakizumab) for Treatment of Plaque Psoriasis in Japan".
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries